Embosphere® 00884450106051Recalls & reported problems
Biosphere Medical · Class 2 · Implant
All models of Embosphere (18)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00884450106051), received between Apr 13, 2026 and Jul 15, 2026 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Device Contamination with Chemical or Other Material1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Thrombosis/Thrombus1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJul 15, 2026Adverse Event Without Identified Device or Use Problem
LITTLE, M. W., O'GRADY, A., BRIGGS, J., GIBSON, M., SPEIRS, A., AL-REKABI, A., YOONG, P., ARIYANAYAGAM, T., DAVIES, N., TAYTON, E., TAVARES, S., MACGILL, S., MCLAREN, C., & HARRISON, R. (2024). GENICULAR ARTERY EMBOLISATION IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE (GENESIS) USING PERMANENT MICROSPHERES: LONG-TERM RESULTS. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 47(12), 1750-1762. HTTPS://DOI.ORG/10.1007/S00270-024-03752-7 WAS REVIEWED DURING INTERNAL QUALITY SYSTEM ACTIVITIES. THE PUBLICATION DESCRIBES ONE PATIENT UNDERGOING GAE THAT DEVELOPED A POPLITEAL DEEP VEIN THROMBOSIS (DVT) 15-DAYS POST-INTERVENTION. THE VENOUS THROMBUS WAS NOT DIRECTLY RELATED TO GAE. MOREOVER, IT WAS RELATED TO IMMOBILITY IN THE POST-OPERATIVE PERIOD. THIS COMPLICATION HIGHLIGHTS THE IMPORTANCE OF EARLY MOBILIZATION POST GAE.
Patient problems: Thrombosis/Thrombus
MAUDE report 25829662 ↗MalfunctionApr 23, 2026Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT DURING PREP FOR A HEPATIC ARTERY EMBOLIZATION, A FOREIGN MATERIAL RESEMBLING A HAIR WAS FOUND IN THE SYRINGE. THIS PRODUCT WAS NOT USED FOR THE PROCEDURE. A NEW DEVICE WAS USED INSTEAD. NO INJURY OR ADDITIONAL MEDICAL TREATMENTS WERE REQUIRED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24964576 ↗MalfunctionApr 13, 2026Break
THE CUSTOMER REPORTS THE TIP OF THE SYRINGE WAS BROKEN PRIOR TO SURGERY. NO PATIENT INVOLVEMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24865378 ↗
Other AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS devices
- Embosphere® 00884450116715Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 recall8 reports
- HydroPearl HP2S0600Microvention, Inc. · Agents, embolic, for treatment of uterine fibroids1 recall0 reports
- Embosphere® 00884450109519Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 recall0 reports
- Embosphere® 00884450098424Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS8 reports
- Embosphere® 00884450098561Biosphere Medical · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS8 reports
- Cook G09665Cook Incorporated · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 report
- Bearing nsPVA® 00884450123348Merit Medical Systems, Inc. · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 report
- Cook G09664Cook Incorporated · AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page